OPERON BUILDNEXT | NEW PRODUCT DESIGN & DEVELOPMENT
Medical Device Design and Development Services in Algeria
Operon Strategist delivers end-to-end medical device design and development services in Algeria, combining engineering precision, usability engineering, and rigorous regulatory compliance. From initial concept creation and CAD modeling to rapid prototyping and verification & validation (V&V) planning, we ensure your device meets clinical needs, ISO 13485 design controls, and ANPP (Agence Nationale des Produits Pharmaceutiques) homologation requirements—right from the start.
Take the next step
Operon BuildNext
New Product Design & Development Service Portfolio
Concept-to-Prototype Design
Translating ideas into structured product concepts
Early-stage feasibility and design planning
Rapid prototyping aligned with intended use
CAD Modeling & Design Refinement
Detailed CAD modeling and drawings
Design optimization for performance and manufacturability
Iterative refinement based on testing feedback
Usability Engineering
User needs analysis and intended use definition
Human factors engineering
Minimizing use errors and improving user experience
Design Validation & Documentation
Verification and validation planning
Design History File (DHF) development
Compliance with ISO 13485 Clause 7.3 & FDA 21 CFR 820.30
Support for regulatory submissions
What Sets Us Apart
150+ Medical Devices Designed & Developed
Diagnostics, Disposables & Electromechanical
Expertise in ISO 13485 & FDA 21 CFR 820.30 Design Controls
End-to-End Support from Concept to Commercialization
From product R&D to audit-ready manufacturing integration—we align device engineering with GMP-compliant production environments across Algeria. By integrating cleanroom zoning, workflow optimization, and comprehensive technical dossier preparation (STED/CSDT), we enable efficient local manufacturing and seamless ANPP authorization from day one.
Operon New Product Design & Development Advantage
Regulatory-compliant plant layout design that ensures operational efficiency, cleanroom readiness, and audit preparedness for medical device manufacturers
Design controls aligned with global regulations
Strong focus on usability & patient safety
Seamless transition from prototype to manufacturing
Integrated regulatory & quality expertise
You Might Also Be Interested in
frequently asked questions
What key stages are included in Operon’s medical device design and development process?
Our design and development methodology follows ISO 13485 and FDA 21 CFR 820.30 design control principles across five structured phases:
Phase 1: Design Input & Planning: Defining user needs, clinical intent, and ANPP regulatory requirements.
Phase 2: Concept & CAD Design: 3D CAD modeling, electrical/mechanical engineering, and usability optimization.
Phase 3: Prototyping & Testing: Rapid prototyping, bench testing, and design iteration.
Phase 4: Design Verification & Validation (V&V): Protocol creation, test execution, and safety standard compliance (IEC 60601, ISO 10993).
Phase 5: Transfer to Manufacturing: Cleanroom production workflow engineering and technical dossier compilation (STED/CSDT).
Why are ISO 13485 design controls essential for medical device registration in Algeria?
The ANPP (Agence Nationale des Produits Pharmaceutiques) requires proof that a medical device is designed, tested, and manufactured under a recognized Quality Management System (QMS). Implementing strict design controls ensures that every design modification, risk assessment, and validation result is fully documented in your Design History File (DHF), forming the core of your local homologation dossier.
What is Verification & Validation (V&V) planning, and why is it critical?
Verification proves that the product was designed correctly (i.e., Does the output meet the specified design inputs and specifications?).
Validation proves that the correct product was designed (i.e., Does the device meet the actual user needs and clinical intent in real-world conditions?).
A robust V&V plan ensures your device passes mandatory physical, electrical, biological, and software safety testing required by international standards and Algerian regulatory inspectors.
How is risk management (ISO 14971) integrated into product development?
Risk management is embedded from day one. We conduct preliminary hazard analyses, Failure Mode and Effects Analysis (FMEA), and risk mitigation reviews during the concept and design stages. This guarantees that all potential patient and operational risks are reduced to acceptable levels before entering prototype fabrication or clinical evaluation.
Can Operon assist with transitioning our prototype to local manufacturing in Algeria?
Yes. Operon BuildNext bridges the gap between R&D and commercial production. Once your design is validated, we assist in establishing local manufacturing workflows, cleanroom specifications (ISO 14644), tooling procurement, and process validation (IQ/OQ/PQ) tailored for production plants in Algeria.A complete product feasibility study and DPR typically takes 4 to 6 weeks, depending on the medical device risk classification (Class I, IIa, IIb, or III), technical complexity, and depth of financial modeling required.
Build a Manufacturing Facility That Passes Audits and Performs Efficiently
Talk to a plant layout consultant